Related references
Note: Only part of the references are listed.The Dark Side of Protein Kinase CK2 Inhibition
G. Cozza et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Phosphorylation of AKT/PKB by CK2 Is Necessary for the AKT-Dependent Up-Regulation of β-Catenin Transcriptional Activity
Daniela P. Ponce et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Inhibits Prosurvival and Angiogenic Signaling and Exhibits Antitumor Efficacy
Adam Siddiqui-Jain et al.
CANCER RESEARCH (2010)
Effects of Fruit Ellagitannin Extracts, Ellagic Acid, and Their Colonic Metabolite, Urolithin A, on Wnt Signaling
Meenakshi Sharma et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2010)
Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism
Mar Larrosa et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2010)
How Druggable Is Protein Kinase CK2?
Giorgio Cozza et al.
MEDICINAL RESEARCH REVIEWS (2010)
Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2
Giorgio Cozza et al.
BIOCHEMICAL JOURNAL (2009)
Structural insight into human CK2α in complex with the potent inhibitor ellagic acid
Yusuke Sekiguchi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Dephosphorylation and inactivation of Akt/PKB is counteracted by protein kinase CK2 in HEK 293T cells
Giovanni Di Maira et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
From birth to death: The role of protein kinase CK2 in the regulation of cell proliferation and survival
N. A. St-Denis et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Too much of a good thing: The role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2
James S. Duncan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2008)
Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: An integrate approach to elucidate the putative binding motif and explain structure-activity relationships
Adriana Chilin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Pomegranate juice and extracts provide similar levels of plasma and urinary ellagitannin metabolites in human subjects
Navindra P. Seeram et al.
JOURNAL OF MEDICINAL FOOD (2008)
The selectivity of protein kinase inhibitors: a further update
Jenny Bain et al.
BIOCHEMICAL JOURNAL (2007)
Tetrabromocinnamic acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitors
Mario A. Pagano et al.
CHEMBIOCHEM (2007)
Identification of ellagic acid as potent inhibitor of protein kinase CK2: A successful example of a virtual screening application
G Cozza et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Protein kinase CK2 phosphorylates and upregulates Akt/PKB
G Di Maira et al.
CELL DEATH AND DIFFERENTIATION (2005)
Inhibition of protein kinase CK2 prevents the progression of glomerulonephritis
M Yamada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Protein kinase CK2 as regulator of cell survival: Implications for cancer therapy
GM Unger et al.
CURRENT CANCER DRUG TARGETS (2004)
Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo study
F Meggio et al.
BIOCHEMISTRY (2004)
Synthesis and biological activities of some new dibenzopyranones and dibenzopyrans: search for potential oestrogen receptor agonists and antagonists
J Pandey et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2004)
Inhibition of protein kinase CK2 by anthraquinone-related compounds - A structural insight
E De Moliner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Protein kinase CK2: structure, regulation and role in cellular decisions of life and death
DW Litchfield
BIOCHEMICAL JOURNAL (2003)
Toward the rational design of protein kinase casein kinase-2 inhibitors
S Sarno et al.
PHARMACOLOGY & THERAPEUTICS (2002)
A potential role of nuclear matrix-associated protein kinase CK2 in protection against drug-induced apoptosis in cancer cells
CH Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)